7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 
      
    		                            
      cash flows from operating activities
    		                            
      net income
    		-38,000,000 -41,930,000 -426,075,000 2,371,000 -60,725,000 -173,319,000 -78,178,000 -82,018,000 -66,869,000 -69,833,000 -88,015,000 -84,384,000 -76,971,000 -71,394,000 -81,499,000 -69,329,000 16,542,000 -41,001,000 -87,435,000 74,935,000 -23,708,000 -23,086,000 1,262,000 -91,000 -29,123,000 -24,596,000 -30,324,000 -30,799,000 
      adjustments to reconcile net income to net cash from operating activities
    		                            
      depreciation
    		2,461,000 2,659,000 5,131,000 2,842,000 4,193,000 3,499,000 3,240,000 2,976,000 2,903,000 2,829,000 2,755,000 2,543,000 2,346,000 2,323,000 2,268,000 2,256,000 1,745,000 1,592,000 1,606,000 1,601,000 1,581,000 1,589,000 1,657,000 1,782,000 1,897,000 1,790,000 1,796,000  
      amortization of intangible assets
    		1,020,000 1,019,000 366,390,000    6,853,000 6,853,000 942,000 232,000 234,000  229,000 228,000 228,000              
      amortization of right-of-use assets
    		921,000 904,000 1,258,000 1,253,000 5,054,000 3,937,000 1,921,000 1,870,000 1,610,000 1,803,000 1,527,000 1,773,000 1,740,000 1,716,000 1,696,000              
      share-based compensation expense
    		10,984,000 11,895,000 9,201,000 16,033,000 18,259,000 17,219,000 19,525,000  19,691,000 17,891,000 17,952,000                  
      impairment charges
    		0 0 15,000,000                          
      accretion of discount and amortization of premium on marketable securities
    		-923,000 -1,276,000 -1,706,000 -2,381,000 -3,091,000 -3,541,000 -4,031,000  -3,975,000 -3,958,000 -2,155,000                  
      change in the estimated fair value of contingent consideration
    		0 0 -18,700,000 -1,950,000 1,170,000 0 -70,000 1,100,000 -271,000 1,975,000 12,256,000 4,598,000 4,280,000 -5,438,000 -1,063,000              
      inventory provision
    		1,226,000 883,000 7,659,000 903,000 -207,000 3,919,000 3,000 5,893,000 396,000 774,000 3,521,000                  
      deferred income taxes
    		0 0 -546,000     -718,000        1,175,000             
      other
    		397,000 340,000 719,000 -1,630,000 300,000 299,000 403,000 392,000        1,000             
      changes in assets and liabilities
    		                            
      accounts receivable
    		1,641,000 -612,000 -4,121,000 1,859,000 3,050,000 -2,110,000 6,292,000 -6,129,000 -6,452,000 5,555,000 -10,803,000 3,970,000 4,302,000 794,000 -3,611,000 -295,000 -3,772,000 -7,030,000 3,931,000 -5,031,000 -460,000 -4,021,000 7,909,000 -5,300,000 2,157,000 -4,844,000 1,316,000 -2,191,000 
      inventory
    		-1,058,000 -1,330,000 -2,538,000 7,074,000 1,373,000 -5,112,000 -11,655,000 9,008,000 -3,146,000 -6,384,000 -13,319,000 -13,206,000 -7,534,000 -6,891,000 -6,275,000 -6,978,000 -423,000 -2,474,000 -2,556,000 1,892,000 834,000 -448,000 -3,374,000 1,660,000 2,295,000 1,848,000 -1,888,000 609,000 
      prepaid expenses and other assets
    		988,000 3,383,000 3,426,000 -1,306,000 -25,000 508,000 3,051,000 -1,697,000 -1,202,000 803,000 -6,888,000 -6,639,000 -5,345,000 845,000 -1,185,000 -1,023,000 306,000 368,000 -675,000 -1,279,000 -308,000 582,000 -58,000 -761,000 -150,000 301,000 87,000 -827,000 
      accounts payable
    		1,266,000 1,020,000 -1,525,000 3,627,000 -5,612,000 -3,254,000 6,644,000 -1,500,000 -2,556,000 -806,000 5,068,000 -486,000 180,000 -5,042,000 6,373,000 6,167,000 -1,207,000 1,250,000 153,000 -2,117,000 -1,916,000 3,090,000 -4,129,000 259,000 769,000 -1,390,000 2,075,000 687,000 
      accrued expenses
    		1,011,000 -2,718,000 311,000 323,000 -3,415,000 503,000 -23,753,000 11,048,000 8,011,000 7,230,000 -13,186,000 7,403,000 303,000 5,877,000 -17,234,000 5,053,000 4,707,000 8,240,000 -2,680,000 2,456,000 2,685,000 -5,760,000 4,721,000 -2,581,000 1,716,000 2,987,000 -1,703,000 3,702,000 
      deferred revenue
    		-123,000 -524,000 1,332,000 -2,983,000 -2,171,000 1,445,000 1,601,000 -5,553,000 -2,550,000 -2,740,000 423,000 -159,000 -1,460,000 -4,064,000 1,949,000 7,806,000 8,528,000 4,398,000 5,004,000 1,547,000 280,000 -128,000 -970,000      
      operating lease liabilities
    		1,069,000 -112,000 -1,618,000 -2,668,000 -4,504,000 -2,372,000 -2,376,000 -2,363,000 -2,282,000 -2,145,000 -1,969,000 -1,819,000 -2,072,000 -1,949,000 -1,884,000 -1,759,000 -1,087,000 -1,078,000 -1,066,000 -1,011,000 -956,000 -904,000 -931,000 -891,000     
      other liabilities
    		-1,587,000 -2,978,000 2,346,000 2,441,000 -5,964,000 4,063,000 -5,152,000 3,596,000 -1,686,000 2,994,000 -2,455,000 2,587,000 -2,079,000 2,891,000 -2,512,000 2,193,000 -2,064,000 2,048,000 -2,980,000 4,686,000 -1,603,000 1,474,000 489,000 -885,000 1,023,000 622,000 -1,323,000 -41,000 
      net cash from operating activities
    		-18,707,000 -29,377,000 -44,056,000 -30,650,000 -45,463,000 -54,263,000 -75,682,000 -57,560,000 -65,181,000 -41,741,000 -94,691,000 -60,566,000 -63,053,000 -60,563,000 -79,029,000 -31,708,000 -40,656,000 -15,712,000 -23,104,000 -14,263,000 -17,808,000 -23,789,000 75,363,000 -18,180,000 -17,260,000 -17,559,000 -25,313,000 -18,985,000 
      capex
    		86,000 -550,000 -1,389,000 -1,617,000 787,000 -1,479,000 -3,879,000 -2,024,000 -830,000 -2,268,000 -3,721,000 -4,904,000 -4,189,000 -4,019,000 -3,638,000 -2,842,000 -1,119,000 -1,569,000 -401,000 -67,000 -536,000 -319,000 -117,000 -141,000 -829,000 -613,000 -1,253,000 -58,000 
      free cash flows
    		-18,621,000 -29,927,000 -45,445,000 -32,267,000 -44,676,000 -55,742,000 -79,561,000 -59,584,000 -66,011,000 -44,009,000 -98,412,000 -65,470,000 -67,242,000 -64,582,000 -82,667,000 -34,550,000 -41,775,000 -17,281,000 -23,505,000 -14,330,000 -18,344,000 -24,108,000 75,246,000 -18,321,000 -18,089,000 -18,172,000 -26,566,000 -19,043,000 
      cash flows from investing activities
    		                            
      purchases of property and equipment
    		86,000 -550,000 -1,389,000                          
      purchases of intangible assets
    		0 0 -5,000,000                          
      purchases of investments
    		-65,825,000 -56,172,000 -61,820,000  -114,600,000 -111,657,000 -191,907,000  -76,869,000                    
      sales of investments
    		   26,795,000    0 0 0 595,000     0 178,177,000 29,960,000 4,597,000     0    0 
      maturities of investments
    		84,641,000 82,005,000 113,443,000 113,531,000 128,817,000 189,973,000 161,650,000 138,268,000 320,124,000 147,265,000 163,864,000 220,375,000 124,910,000 108,455,000 122,060,000 199,220,000 73,110,000 81,775,000 68,400,000 38,900,000 52,250,000 43,700,000 18,750,000 11,750,000 24,950,000 27,550,000 56,860,000 12,500,000 
      net cash from investing activities
    		18,902,000 25,283,000 45,234,000 58,238,000 23,065,000 76,837,000 -34,136,000  242,323,000 -98,591,000 -72,553,000  53,908,000 -60,281,000 42,053,000  -291,646,000 -460,808,000 8,170,000  -63,641,000 -2,859,000 -54,327,000  19,659,000 7,812,000 37,984,000 -5,513,000 
      cash flows from financing activities
    		                            
      proceeds from issuance of common stock from equity plans
    		1,469,000 0 1,959,000 0 812,000 0 6,891,000 936,000 4,562,000 2,586,000 7,235,000 1,247,000 3,543,000 848,000 5,592,000 1,685,000 4,810,000 2,968,000 22,343,000 32,186,000 13,347,000 628,000 199,000 131,000 327,000 1,400,000 6,690,000 5,471,000 
      notes payable principal payoff
    		    0 -152,000 -338,000 -445,000 -486,000 -465,000 -446,000 -428,000 -410,000 -393,000 -377,000     0 0 0 -16,000,000      
      net cash from financing activities
    		1,469,000 0 1,959,000  812,000 -152,000 6,553,000 -81,602,000 -781,000 -4,715,000 195,989,000 819,000 3,133,000 455,000 5,215,000 1,324,000 299,656,000 2,880,000 865,721,000 125,877,000 107,135,000 628,000 18,199,000 18,131,000 327,000 1,400,000 6,690,000 5,279,000 
      net increase in cash, cash equivalents, and restricted cash
    		  3,137,000    -103,265,000 -205,737,000   28,745,000 20,656,000                 
      cash, cash equivalents, and restricted cash at beginning of period
    		0 0 57,592,000  0 0 182,633,000 0 0 0 328,311,000 0                 
      cash, cash equivalents, and restricted cash at end of period
    		1,664,000 -4,094,000 60,729,000  -21,586,000 22,422,000 79,368,000 -205,737,000 176,361,000 -145,047,000 357,056,000 20,656,000                 
      cash and cash equivalents at end of period
    		1,664,000 -3,704,000 58,507,000  -21,544,000 22,880,000 76,646,000 -205,737,000 176,361,000 -144,547,000 353,834,000 20,656,000 -6,012,000 -118,129,000 428,574,000 35,337,000 -34,406,000 -472,604,000 932,398,000 12,583,000 25,686,000 -25,520,000 68,862,000 -3,457,000 2,726,000 -7,847,000 38,205,000 -19,219,000 
      restricted cash at end of period
    		0 -390,000 2,222,000  -42,000 -458,000 2,722,000 0 0 -500,000 3,222,000 0 0 -2,260,000 5,482,000 32,000 1,760,000 -1,036,000 4,336,000 836,000 0 -500,000 4,000,000 0 0 -500,000 4,500,000 0 
      supplemental disclosure of non-cash investing and financing activities
    		                            
      right-of-use asset and lease liability recognized due to lease extension
    		0 0 29,575,000                          
      net decrease in cash, cash equivalents, and restricted cash
    		                            
      merger-related compensation expense
    		       0                     
      loss on extinguishment of debt
    		       0 0                    
      gain on debt restructuring
    		                            
      contingent consideration liability
    		       -14,150,000                     
      purchase of property and equipment
    		   -1,617,000 787,000 -1,479,000 -3,879,000 -2,024,000 -830,000 -2,268,000 -3,721,000 -4,904,000 -4,189,000 -4,019,000 -3,638,000 -2,842,000 -1,119,000 -1,569,000 -401,000 -67,000 -536,000 -319,000 -117,000 -141,000 -829,000 -613,000 -1,253,000 -58,000 
      purchase of intangible assets
    		                            
      cash paid for purchases of acquired entities, net of cash acquired
    		                            
      purchase of investments
    		          -233,291,000 -134,889,000 -66,813,000 -164,717,000 -76,369,000 -130,625,000 -222,021,000 -570,974,000 -64,426,000 -138,728,000 -115,355,000 -46,240,000 -72,960,000 -15,017,000 -5,962,000 -19,125,000 -17,623,000 -17,955,000 
      proceeds from issuance of common stock under equity offerings, net of issuance costs
    		       0 0 0 189,200,000     -1,000             
      payment of debt issuance costs
    		       -50,000 -489,000                    
      payment of contingent consideration
    		       -82,043,000                     
      amortization of acquired intangible assets
    		    6,852,000                        
      goodwill impairment
    		    0                        
      cash paid for purchase of apton, net of cash acquired
    		                            
      gain from continuation advances
    		               0 0 0 52,000,000  0 0 -34,000,000      
      share-based compensation
    		                            
      amortization of premium and accretion of discount on marketable securities
    		           -1,313,000                 
      net cash from in investing activities
    		                            
      continuation advances
    		               0 0 0 -52,000,000  0        
      proceeds from issuance of convertible senior notes, net of issuance costs
    		               0 0 -88,000 895,624,000          
      supplemental disclosure of cash flow information
    		                            
      interest paid
    		                            
      inventory transferred to property and equipment
    		                   556,000 175,000   278,000 357,000   1,207,000 
      property and equipment transferred to inventory
    		                            
      right-of-use asset and liability additions and modifications
    		                            
      issuance of common stock in acquisition of apton and omniome
    		                            
      issuance of common stock in connection with apton liquidity event bonus plan
    		                            
      convertible senior notes exchange
    		                            
      issuance of common stock following milestone achievement
    		                            
      amortization of debt discount and financing costs
    		         162,000 162,000 160,000 161,000 160,000 159,000 158,000 155,000 152,000 74,000 0 0 0 129,000 325,000 313,000 295,000 279,000 275,000 
      loss on disposition of equipment
    		         -156,000 201,000 196,000 5,000 -23,000 100,000              
      amortization of intangibles
    		                            
      cash paid for purchase of circulomics, net of cash acquired
    		               0             
      cash paid for purchase of omniome, net of cash acquired
    		               0             
      issuance of common stock in acquisition of omniome
    		               1,000             
      income from continuation advances
    		                            
      stock-based compensation
    		            18,936,000 19,019,000 22,703,000 18,938,000 28,447,000 15,805,000 10,165,000 5,275,000 4,992,000 3,234,000 4,032,000 3,869,000 4,062,000 4,089,000 4,381,000 7,522,000 
      amortization from investment premium
    		             385,000 758,000              
      net increase in cash and cash equivalents and restricted cash
    		             -120,389,000 -31,761,000 35,369,000 -32,646,000 -473,640,000 850,787,000 13,119,000 25,686,000 -26,020,000 39,235,000 -3,457,000 2,726,000 -8,347,000 19,361,000  
      cash and cash equivalents and restricted cash at beginning of period
    		             0 465,817,000 0 0 0 85,947,000 300,000 0 0 33,627,000 0 0 0 23,344,000 0 
      cash and cash equivalents and restricted cash at end of period
    		             -120,389,000 434,056,000 35,369,000 -32,646,000 -473,640,000 936,734,000 13,419,000 25,686,000 -26,020,000 72,862,000 -3,457,000 2,726,000 -8,347,000 42,705,000 -19,219,000 
      income from derivative
    		                            
      amortization
    		               904,000 1,325,000 1,217,000 565,000  36,000 -94,000 -83,000    -416,000  
      amortization of operating lease right-of-use assets
    		                812,000 801,000 790,000  735,000 683,000 709,000  665,000 636,000 653,000  
      deferred gain from reverse termination fee
    		                    0 0 98,000,000      
      issuance costs paid for underwritten public equity offering
    		                 0 -246,000          
      gain from continuation advances from illumina
    		                            
      (gain) income from derivative
    		                            
      amortization and accretion for investment premium
    		                            
      continuation advances from illumina
    		                            
      proceeds from issuance of common stock from underwritten public equity offerings, net of issuance costs
    		                            
      gain on derivative
    		                         0 -16,000  
      proceeds from issuance of common stock from underwritten public equity offering, net of issuance costs
    		                            
      supplemental disclosure of non-cash operating activities
    		                            
      inventory transferred from property and equipment
    		                        2,194,000    
      proceeds from continuation advances
    		                      34,000,000      
      loss on return of building under capital lease
    		                            
      proceeds from disposal of property and equipment
    		                            
      proceeds from issuance of common stock from "at-the-market" offerings, net of issuance costs
    		                            
      property and equipment paid for by landlord
    		                            
      changes in deposits for property and equipment paid in prior period
    		                            
      property and equipment returned to landlord
    		                            
      (gain) loss on derivative
    		                            
      accretion from investment discount
    		                        -144,000    
      (gain) loss on disposition of equipment
    		                            
      deferred service revenue
    		                        -347,000 964,000 -230,000 671,000 
      depreciation and amortization
    		                            
      non-cash portion of gain on lease amendments
    		                            
      deferred contractual revenue
    		                            
      net decrease in cash and cash equivalents and restricted cash
    		                            
      property and equipment paid by landlord
    		                            
      other items
    		                            
      disposal of property and equipment
    		                            
      notes payable principal payment
    		                            
      proceeds from issuance of common stock from at-the-market equity offering, net of issuance costs
    		                            
      changes in unpaid property and equipment
    		                            
      notes payable principal paying off
    		                            
      impact from adoption of asc 606 revenue from contracts with customers
    		                            
      inventory transferred to (from) property and equipment
    		                            
      long-term restricted cash
    		                            
      proceeds from issuance of common stock from "at-the-market" offering, net of issuance costs
    		                            
      net decrease in cash and cash equivalents
    		                            
      cash and cash equivalents at beginning of period
    		                            
      net increase in cash and cash equivalents
    		                            
      proceeds from issuance of common stock from underwritten public equity offering, net of issue costs
    		                            
      purchase of property and equipment through accounts payable
    		                            
      instruments that were transferred from inventory to property and equipment
    		                            
      proceeds from issuance of debt agreement, net of issuance costs
    		                            
      leased instruments that were transferred from inventory to property and equipment
    		                            
      inventory transferred to (from) property and equipment for internal use
    		                            
      proceeds from issuance of facility agreement, net of issuance costs
    		                            
      accrued expenses and other current liabilities
    		                            
      deferred rent and other long-term liabilities
    		                            
      other long-term liabilities
    		                            
      proceeds from issuance of common stock, net of issuance costs
    		                            
      proceeds from issuance of debt facility, net of issuance costs
    		                            
      lease incentives and other long-term liabilities
    		                            
      proceeds from issuance of convertible preferred stock
    		                            
      proceeds from issuance of common stock
    		                            
      assets acquired under facility lease
    		                            
      additions to property and equipment under tenant improvement allowances
    		                            
      inventory transferred to property and equipment for internal use
    		                            
      conversion of convertible preferred stock to common stock upon ipo
    		                            
      reclassification of preferred warrants to common stock warrants
    		                            
      issuance of common stock related to convertible preferred stock offering
    		                            
      vesting of stock options related to early exercises
    		                            
      purchases of property and equipment through accrued liabilities
    		                            
      proceeds from exercise of junior preferred stock options
    		                            
      proceeds from issuance of common stock in ipo, net of issuance costs
    		                            
      repurchases of common stock
    		                            
      payment of notes payable
    		                            
      assets acquired under facility financing obligation
    		                            
      prepaid expenses and other current assets
    		                            
      other long-term assets
    		                            
      sales and maturities of investments
    		                            
      proceeds from exercise of common stock options
    		                            
      repurchases of junior preferred stock
    		                            
      issuance of convertible preferred stock warrants
    		                            
      reclassification of convertible preferred stock warrants to liabilities
    		                            
      amortization of deferred financing costs
    		                            
      change in convertible preferred stock warrant liability fair value
    		                            
      proceeds from issuance of notes payable
    		                            
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.